Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
2020 · Nature Communications · 144 citations
https://doi.org/10.1038/s41467-020-18245-7
A
Arta M. Monjazeb
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
209
Papers
6.0K
Citations
41
h-index
95
i10-index
Arta M. Monjazeb is an academic researcher from University of California System. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 41, co-authored 178 publications.
ORCID: 0000-0001-5175-8004Papers by this author
worksConservative management of desmoid tumors is safe and effective
2016 · Journal of Surgical Research · 27 citations
https://doi.org/10.1016/j.jss.2016.06.028
Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels
2014 · Biology of Blood and Marrow Transplantation · 24 citations
https://doi.org/10.1016/j.bbmt.2014.07.022
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data
2023 · Seminars in Cancer Biology · 22 citations
https://doi.org/10.1016/j.semcancer.2023.07.004
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
2025 · The Lancet Oncology · 19 citations
https://doi.org/10.1016/s1470-2045(24)00656-9
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
2023 · Nature Communications · 18 citations
https://doi.org/10.1038/s41467-023-40813-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat